Company / Free Cash Flow
Ginkgo Bioworks Holdings, Inc. Free Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$178.7M
FY2025
5-year range
-$382.1M / -$178.7M
FY2021-FY2025
Trend
+53.2%
vs FY2024
Sector context
#142 of 192
Health Care
What the data says
At -$179M, Ginkgo Bioworks Holdings, Inc.'s free cash flow ranks #142 of 192 in the Health Care sector. Free Cash Flow returned to growth in FY2025 after 2 years of decline, reaching -$179M.
Based on SEC 10-K filings.
-$179M in FY2025.
Improved from -$336M to -$179M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#142 of 192 in Health CareTop 74% of 192This company -$178.7M Sector average $474.2M
▼
-137.7% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 53.2% year-over-year.
- Ranks #142 out of 192 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2019.
- Lowest free cash flow in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$178.7M | +53.2% |
| FY2024 | -$382.1M | -13.6% |
| FY2023 | -$336.3M | -10.5% |
| FY2022 | -$304.5M | +1.9% |
| FY2021 | -$310.3M | -60.3% |
| FY2020 | -$193.7M | -189.5% |
| FY2019 | -$66.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026